Control Empresarial de Capitales S.A. de C.V. bought $630K of ProKidney (PROK)
Executed Apr 10 2025, disclosed Apr 14 2025, 4 days later.
Over the 21 trading sessions from the disclosed entry session (Apr 14 2025), the stock returned +9.9% (delay-adjusted); from the execution session (Apr 10 2025), +19.4%. Derived: entry at the session's open, exit at the close 20 sessions later.
Control Empresarial de Capitales S.A. de C.V. (10% owner) filed 57 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 57 sales), most often in PBF Energy Inc. (PBF). The largest single filing was $106.8M of TALO (6,240,000 sh across 3 lots, as filed), executed Oct 8.
Healthcare · ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney d…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→387,393 sh × $0.71
Exec Apr 22 2025
Filed Apr 24 2025 · 5:30 PM ET PROKPURCHASE ProKidney Corp. $523K
736,105 sh across 2 lots
Exec Apr 14 2025
Filed Apr 16 2025 · 5:30 PM ET